top of page
Home_banner_3.jpg

Abstracts

These resources are for SETGYC Congress delegates only. Please do not share.

Abstracts

OR04

Cell and gene therapy of skin, skeletal & cardiac muscles

Ainhoa Irastorza-Lorenzo

Biodonostia Institute, San Sebastian

Development of biomimetic tympanic membrane substitutes for the treatment of chronic perforations

OR05

Cell and gene cancer immunotherapy

Alvaro Morales-Molina

Instituto de Salud Carlos III, Madrid

Using silent cells improves tumor homing and efficacy of of cell therapy for cancer

OR06

Cell and gene cancer immunotherapy

Cristian Smerdou

CIMA, Pamplona

Expression of Galectin-3 inhibitors from a self-replicating RNA vector as treatment for pediatric osteosarcoma

OR07

Cell and gene therapy of metabolic diseases

Maria Garcia-Bravo

Division of Cell Technology, Biomedical Innovation Unit, CIEMAT, CIBERER, IIS-FJD, UAM, Madrid


Hyperoxaluric phenotype improvement after in vivo lentiviral vector gene therapy in a preclinical model of Primary Hyperoxaluria Type 1

OR08

Cell and gene therapy of skin, skeletal & cardiac muscles

Araceli Aguilar-González

GENyO- Centro de Genomica e Investigacion Oncologica: Pfizer / Universidad de Granada / Junta de Andalucia


Isogenic GAA-KO murine muscle cell lines mimicking severe Pompe mutations as preclinical models for screening of potential gene therapy strategies

OR09

CAR-T cells

Angel Martin Mallo

Cima Universidad de Navarra. IdiSNA.


Effect of the disease stage over the phenotype and functionality of CAR-T cells in multiple myeloma patients

OR10

Cell and gene cancer immunotherapy

Diego Sanchez-Martínez

Josep Carreras Leukemia Research Institute


Efficient treatment of cortical T cell acute lymphoblastic leukemia with T lymphocytes secreting anti-AntigenA T cell engagers

OR11

Cell and gene therapy of Neural diseases

Sergi Verdés

Institut de Neurociències (INc), Universitat Autònoma de Barcelona (UAB)


Gene therapy for ALS by specifically overexpressing a pleiotropic chronokine, secreted α-Klotho (s-KL), in skeletal muscles

OR12

CAR-T cells

Nieves Iria Domínguez-García

Instituto de Biomedicina de Sevilla (IBiS)


Pathophysiological alterations of regulatory T cells in Parkinson's disease and generation of aSyn-CAR-Tregs as a novel therapeutic approach.

OR13

Cell and gene therapy of blood disorders

Gonzalo Martinez-Navaja

University of Granada

Correction of haematopoietic stem cells from Bernard-Soulier syndrome patients and disease models by gene therapy

OR14

Cell and gene therapy of blood disorders

Yari Gimenez-Martinez

CIEMAT, CIBERER, IIS-FJD, UAM, Madrid

Towards Lentiviral Gene Therapy for RPS19-Diamond Blackfan Anemia Patients

OR15

Cell and gene therapy of skin, skeletal & cardiac muscles

Leire Gardeazabal

Biodonostia Institute, San Sebastian


Alterations in extracellular matrix deposition by wound bed fibroblasts during cutaneous wound healing of aged Sox2EGFP mice

bottom of page